These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 34404759)

  • 21. Antibody Response to SARS-CoV-2 Membrane Protein in Patients of the Acute and Convalescent Phase of COVID-19.
    Jörrißen P; Schütz P; Weiand M; Vollenberg R; Schrempf IM; Ochs K; Frömmel C; Tepasse PR; Schmidt H; Zibert A
    Front Immunol; 2021; 12():679841. PubMed ID: 34421894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profile of Immunoglobulin G and IgM Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Qu J; Wu C; Li X; Zhang G; Jiang Z; Li X; Zhu Q; Liu L
    Clin Infect Dis; 2020 Nov; 71(16):2255-2258. PubMed ID: 32337590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microarray-Based Detection of Antibodies against SARS-CoV-2 Proteins, Common Respiratory Viruses and Type I Interferons.
    Savvateeva E; Filippova M; Valuev-Elliston V; Nuralieva N; Yukina M; Troshina E; Baklaushev V; Ivanov A; Gryadunov D
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal and proteome-wide analyses of antibodies in COVID-19 patients reveal features of the humoral immune response to SARS-CoV-2.
    Wang J; Yang Y; Liang T; Yang N; Li T; Zheng C; Ning N; Luo D; Yang X; He Z; Yang G; Li B; Gao J; Yu W; Gong S; Huang Y; Li J; Wang H; Zhang H; Zhang T; Li P; Li Y; Dai J; Zhang X; Li B; Yu X; Wang H
    J Adv Res; 2022 Mar; 37():209-219. PubMed ID: 35475278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epitope-specific antibody responses differentiate COVID-19 outcomes and variants of concern.
    Voss C; Esmail S; Liu X; Knauer MJ; Ackloo S; Kaneko T; Lowes L; Stogios P; Seitova A; Hutchinson A; Yusifov F; Skarina T; Evdokimova E; Loppnau P; Ghiabi P; Haijan T; Zhong S; Abdoh H; Hedley BD; Bhayana V; Martin CM; Slessarev M; Chin-Yee B; Fraser DD; Chin-Yee I; Li SS
    JCI Insight; 2021 Jul; 6(13):. PubMed ID: 34081630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgM and IgG Profiles Reveal Peculiar Features of Humoral Immunity Response to SARS-CoV-2 Infection.
    De Donno A; Lobreglio G; Panico A; Grassi T; Bagordo F; Bozzetti MP; Massari S; Siculella L; Damiano F; Guerra F; Greco M; Chicone M; Lazzari R; Alifano P
    Int J Environ Res Public Health; 2021 Feb; 18(3):. PubMed ID: 33535692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19-convalescent individuals.
    Li M; Liu J; Lu R; Zhang Y; Du M; Xing M; Wu Z; Kong X; Zhu Y; Zhou X; Hu L; Zhang C; Zhou D; Jin X
    J Allergy Clin Immunol; 2022 Apr; 149(4):1225-1241. PubMed ID: 35074422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients.
    Tornesello AL; Botti C; Micillo A; Labonia F; Arpino S; Isgrò MA; Meola S; Russo L; Cavalcanti E; Sale S; Nicastro C; Atripaldi L; Starita N; Cerasuolo A; Reimer U; Holenya P; Buonaguro L; Buonaguro FM; Tornesello ML
    J Transl Med; 2023 Feb; 21(1):123. PubMed ID: 36788606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients.
    Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W
    Front Immunol; 2021; 12():684014. PubMed ID: 34194438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA, and IgM antibodies.
    Tré-Hardy M; Wilmet A; Beukinga I; Favresse J; Dogné JM; Douxfils J; Blairon L
    J Med Virol; 2021 Feb; 93(2):803-811. PubMed ID: 32667733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence of COVID-19 Symptoms During SARS-CoV-2 Infection Defines Waning of Humoral Immunity.
    Wu J; Liang BY; Fang YH; Wang H; Yang XL; Shen S; Chen LK; Li SM; Lu SH; Xiang TD; Liu J; Le-Trilling VTK; Lu MJ; Yang DL; Deng F; Dittmer U; Trilling M; Zheng X
    Front Immunol; 2021; 12():722027. PubMed ID: 34489971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SARS-CoV-2-induced humoral immunity through B cell epitope analysis in COVID-19 infected individuals.
    Yoshida S; Ono C; Hayashi H; Fukumoto S; Shiraishi S; Tomono K; Arase H; Matsuura Y; Nakagami H
    Sci Rep; 2021 Mar; 11(1):5934. PubMed ID: 33723294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis.
    Li Z; Yi Y; Luo X; Xiong N; Liu Y; Li S; Sun R; Wang Y; Hu B; Chen W; Zhang Y; Wang J; Huang B; Lin Y; Yang J; Cai W; Wang X; Cheng J; Chen Z; Sun K; Pan W; Zhan Z; Chen L; Ye F
    J Med Virol; 2020 Sep; 92(9):1518-1524. PubMed ID: 32104917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Henss L; Scholz T; von Rhein C; Wieters I; Borgans F; Eberhardt FJ; Zacharowski K; Ciesek S; Rohde G; Vehreschild M; Stephan C; Wolf T; Hofmann-Winkler H; Scheiblauer H; Schnierle BS
    J Infect Dis; 2021 Jan; 223(1):56-61. PubMed ID: 33128369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of humoral responses in COVID-19 using various quantitative antibody tests.
    Wakui M; Uwamino Y; Kurafuji T; Noguchi M; Ohno A; Yokota H; Kikuchi H; Hasegawa N; Saya H; Murata M
    Ann Clin Biochem; 2021 Jul; 58(4):368-376. PubMed ID: 33730868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution.
    Wang H; Wu X; Zhang X; Hou X; Liang T; Wang D; Teng F; Dai J; Duan H; Guo S; Li Y; Yu X
    ACS Cent Sci; 2020 Dec; 6(12):2238-2249. PubMed ID: 33372199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of antibody responses to SARS-CoV-2 in convalescent COVID-19 patients.
    Liu C; Yu X; Gao C; Zhang L; Zhai H; Hu Y; Liu E; Wang Q; Gao Y; Wei D; Zhang D; Han Y; Zhang X
    J Med Virol; 2021 Apr; 93(4):2227-2233. PubMed ID: 33135795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients.
    Frasca D; Reidy L; Cray C; Diaz A; Romero M; Kahl K; Blomberg BB
    PLoS One; 2021; 16(3):e0245424. PubMed ID: 33760825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.